Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Erratum: Hong, E., et al. Toll-Like Receptor-Mediated Recognition of Nucleic Acid Nanoparticles (NANPs) in Human Primary Blood Cells. Molecules 2019, 24, 1094.

Hong E, Halman JR, Shah A, Cedrone E, Truong N, Afonin KA, Dobrovolskaia MA.

Molecules. 2019 Oct 25;24(21). pii: E3852. doi: 10.3390/molecules24213852.

2.

A cationic amphiphilic co-polymer as a carrier of nucleic acid nanoparticles (Nanps) for controlled gene silencing, immunostimulation, and biodistribution.

Halman JR, Kim KT, Gwak SJ, Pace R, Johnson MB, Chandler MR, Rackley L, Viard M, Marriott I, Lee JS, Afonin KA.

Nanomedicine. 2019 Oct 25;23:102094. doi: 10.1016/j.nano.2019.102094. [Epub ahead of print]

PMID:
31669854
3.

Editorial for the Special Issue on "Nucleic Acid Architectures for Therapeutics, Diagnostics, Devices and Materials".

Halman JR, Afonin KA.

Nanomaterials (Basel). 2019 Jun 30;9(7). pii: E951. doi: 10.3390/nano9070951.

4.

RNA Fibers as Optimized Nanoscaffolds for siRNA Coordination and Reduced Immunological Recognition.

Rackley L, Stewart JM, Salotti J, Krokhotin A, Shah A, Halman JR, Juneja R, Smollett J, Lee L, Roark K, Viard M, Tarannum M, Vivero-Escoto J, Johnson PF, Dobrovolskaia MA, Dokholyan NV, Franco E, Afonin KA.

Adv Funct Mater. 2018 Nov 28;28(48). pii: 1805959. doi: 10.1002/adfm.201805959. Epub 2018 Oct 9.

5.

Toll-Like Receptor-Mediated Recognition of Nucleic Acid Nanoparticles (NANPs) in Human Primary Blood Cells.

Hong E, Halman JR, Shah A, Cedrone E, Truong N, Afonin KA, Dobrovolskaia MA.

Molecules. 2019 Mar 20;24(6). pii: E1094. doi: 10.3390/molecules24061094. Erratum in: Molecules. 2019 Oct 25;24(21):.

6.

Magnetic nanoparticles loaded with functional RNA nanoparticles.

Cruz-Acuña M, Halman JR, Afonin KA, Dobson J, Rinaldi C.

Nanoscale. 2018 Sep 27;10(37):17761-17770. doi: 10.1039/c8nr04254c.

PMID:
30215080
7.

Structure and Composition Define Immunorecognition of Nucleic Acid Nanoparticles.

Hong E, Halman JR, Shah AB, Khisamutdinov EF, Dobrovolskaia MA, Afonin KA.

Nano Lett. 2018 Jul 11;18(7):4309-4321. doi: 10.1021/acs.nanolett.8b01283. Epub 2018 Jun 20.

8.

Programmable Nucleic Acid Based Polygons with Controlled Neuroimmunomodulatory Properties for Predictive QSAR Modeling.

Johnson MB, Halman JR, Satterwhite E, Zakharov AV, Bui MN, Benkato K, Goldsworthy V, Kim T, Hong E, Dobrovolskaia MA, Khisamutdinov EF, Marriott I, Afonin KA.

Small. 2017 Nov;13(42). doi: 10.1002/smll.201701255. Epub 2017 Sep 18.

9.

Picomolar Fingerprinting of Nucleic Acid Nanoparticles Using Solid-State Nanopores.

Alibakhshi MA, Halman JR, Wilson J, Aksimentiev A, Afonin KA, Wanunu M.

ACS Nano. 2017 Oct 24;11(10):9701-9710. doi: 10.1021/acsnano.7b04923. Epub 2017 Sep 11.

10.

Functionally-interdependent shape-switching nanoparticles with controllable properties.

Halman JR, Satterwhite E, Roark B, Chandler M, Viard M, Ivanina A, Bindewald E, Kasprzak WK, Panigaj M, Bui MN, Lu JS, Miller J, Khisamutdinov EF, Shapiro BA, Dobrovolskaia MA, Afonin KA.

Nucleic Acids Res. 2017 Feb 28;45(4):2210-2220. doi: 10.1093/nar/gkx008.

11.

TGFβ2-induced outflow alterations in a bioengineered trabecular meshwork are offset by a rho-associated kinase inhibitor.

Torrejon KY, Papke EL, Halman JR, Bergkvist M, Danias J, Sharfstein ST, Xie Y.

Sci Rep. 2016 Dec 7;6:38319. doi: 10.1038/srep38319.

12.

Bioengineered glaucomatous 3D human trabecular meshwork as an in vitro disease model.

Torrejon KY, Papke EL, Halman JR, Stolwijk J, Dautriche CN, Bergkvist M, Danias J, Sharfstein ST, Xie Y.

Biotechnol Bioeng. 2016 Jun;113(6):1357-68. doi: 10.1002/bit.25899. Epub 2015 Dec 30.

Supplemental Content

Loading ...
Support Center